As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 4/29/24  BML Investment Partners, L.P.     SC 13G/A               1:70K  Adverum Biotechnologies, Inc.                              
  4/2/24  BML Investment Partners, L.P.     SC 13G                 1:48K  Instil Bio, Inc.                                           
 3/19/24  BML Investment Partners, L.P.     SC 13G/A               1:66K  Cyteir Therapeutics, Inc.                                  
  2/8/24  BML Investment Partners, L.P.     SC 13G/A               1:48K  Aclaris Therapeutics, Inc.        BML Capital Mgmt, LLC    
  2/7/24  BML Investment Partners, L.P.     SC 13G/A               1:65K  Tourmaline Bio, Inc.              BML Capital Mgmt, LLC    
  2/7/24  BML Investment Partners, L.P.     SC 13G/A               1:67K  Cyteir Therapeutics, Inc.         BML Capital Mgmt, LLC    
  2/7/24  BML Investment Partners, L.P.     SC 13G/A               1:48K  Surrozen, Inc./DE                 BML Capital Mgmt, LLC    
  2/7/24  BML Investment Partners, L.P.     SC 13G/A               1:53K  ARCA biopharma, Inc.              BML Capital Mgmt, LLC    
  2/7/24  BML Investment Partners, L.P.     SC 13G/A               1:68K  Tilly’s, Inc.                     BML Capital Mgmt, LLC    
  2/7/24  BML Investment Partners, L.P.     SC 13G/A               1:66K  Enliven Therapeutics, Inc.        BML Capital Mgmt, LLC    
  2/7/24  BML Investment Partners, L.P.     SC 13G/A               1:71K  Eliem Therapeutics, Inc.          BML Capital Mgmt, LLC    
  2/7/24  BML Investment Partners, L.P.     SC 13G/A               1:70K  Adverum Biotechnologies, Inc.     BML Capital Mgmt, LLC    
  2/7/24  BML Investment Partners, L.P.     SC 13G/A               1:65K  CalciMedica, Inc.                 BML Capital Mgmt, LLC    
  2/7/24  BML Investment Partners, L.P.     SC 13G/A               1:68K  Quince Therapeutics, Inc.         BML Capital Mgmt, LLC    
  2/7/24  BML Investment Partners, L.P.     SC 13G/A               1:66K  AVROBIO, Inc.                     BML Capital Mgmt, LLC    
  2/7/24  BML Investment Partners, L.P.     SC 13G/A               1:68K  Atea Pharmaceuticals, Inc.        BML Capital Mgmt, LLC    
  2/7/24  BML Investment Partners, L.P.     SC 13G                 1:68K  Atea Pharmaceuticals, Inc.        BML Capital Mgmt, LLC    
 1/17/24‡ BML Investment Partners, L.P.     SC 13G      1/16/24    1:67K  Reneo Pharmaceuticals, Inc.       BML Capital Mgmt, LLC    
 1/16/24  BML Investment Partners, L.P.     SC 13G                 1:47K  Aclaris Therapeutics, Inc.        BML Capital Mgmt, LLC    
 1/11/24‡ BML Investment Partners, L.P.     SC 13D/A    1/10/24    3:455K Forte Biosciences, Inc.           BML Capital Mgmt, LLC    

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:  -K
	SC 13D	Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.